We have been running mRNAseq on an Illumina GAll. At cycle 36 we are seeing a spike in our error rate. Has anyone else observed this? We do not see it when we run genomic dna or in our standard.
-
-
Bruce,
I have what may be a solution/explanation of your problem, but I'd strongly recommend that you contact Illumina's tech support team as they can help you work through the issue.
Our R&D group used to see higher error rates when they first starting running mRNA-Seq samples longer than 36 reads. It turns out they were sequencing libraries with relatively short inserts (<50 bases). They were reading across the entire insert and in to the adapter sequence on the other side (and since the adapter doesn't align to the genome, you get higher error rates). Libraries with consistently larger inserts are needed when sequencing out to 75 or 100 bases (or beyond). Hopefully this will help you with what you're seeing.
Sincerely,
Shawn C. Baker
Market Manager, Expression and Regulation
Illumina
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Today, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Comment